Global CMC expectations for complex products across major agencies CMC Lifecycle Management for Complex Products: Regulatory Expectations Across Major Agencies Context Regulatory Affairs (RA) professionals face increasing complexities in the development and approval of combination products, sterile injectables, inhalation products, and Advanced Therapy Medicinal Products (ATMPs). The intricate manufacturing processes and specialized CMC (Chemistry, Manufacturing, and Controls) requirements present unique challenges that necessitate a thorough understanding of the regulatory framework, agency expectations, and technical guidelines established in the US, EU, and UK. Legal/Regulatory Basis The regulatory landscape for CMC focuses on ensuring the quality, safety, and efficacy of complex products…

Scaling manufacturing for complex injectables without losing control Scaling Manufacturing for Complex Injectables Without Losing Control Regulatory Affairs Context In the pharmaceutical and biotechnology industries, chemistry, manufacturing, and controls (CMC) for complex products such as sterile injectables, inhalation products, and advanced therapy medicinal products (ATMPs) present unique challenges. Regulatory affairs (RA) professionals need to navigate a complex landscape of guidelines and expectations defined by regulatory authorities like the FDA (U.S.), EMA (Europe), and MHRA (U.K.). This article serves as a detailed regulatory explainer manual to help professionals manage the CMC lifecycle effectively, ensuring compliance while scaling up manufacturing operations. Legal/Regulatory…

Platform versus Bespoke CMC Approaches for Advanced Modalities Platform versus Bespoke CMC Approaches for Advanced Modalities Context In the rapidly evolving landscape of pharmaceutical development, the manufacturing and control (CMC) of complex products such as sterile injectables, inhalation products, and advanced therapy medicinal products (ATMPs) presents unique challenges. Regulatory Affairs (RA) professionals must be adept in determining the most suitable approaches for CMC development. Two primary strategies exist in CMC: platform approach and bespoke approach. Choosing between these can significantly influence regulatory strategy and ultimately affect product approval success. This article delineates these approaches within the context of regulatory expectations…

Tech transfer strategies for complex dosage forms and ATMPs Tech Transfer Strategies for Complex Dosage Forms and ATMPs Context In the ever-evolving landscape of pharmaceutical development, regulatory affairs (RA) professionals play a pivotal role, especially concerning the chemistry, manufacturing, and controls (CMC) of complex products such as injectables, inhalation therapies, and advanced therapy medicinal products (ATMPs). These dosage forms present unique challenges and necessitate thorough understanding and strategic planning during tech transfer processes. This article serves as a comprehensive regulatory explainer manual detailing the overarching regulations, guidelines, and core principles driving the tech transfer of complex dosage forms and ATMPs…

Inspection readiness focus areas for complex product CMC programs Inspection Readiness Focus Areas for Complex Product CMC Programs In the rapidly evolving landscape of pharmaceutical and biotech development, ensuring compliance with regulatory expectations for complex products, such as sterile injectables, inhalation products, advanced therapy medicinal products (ATMPs), and combination products, is critical. As CMC (Chemistry, Manufacturing, and Controls) professionals navigate these challenges, understanding the legal and regulatory framework is essential for achieving inspection readiness. Regulatory Affairs Context Regulatory Affairs (RA) plays a pivotal role in ensuring that pharmaceutical and biotech products meet the required regulatory standards set forth by national…